Microbicidal activity of MDI-P against Candida albicans, Staphylococcus aureus, Pseudomonas aeruginosa, and Legionella pneumophila

American Journal of Infection Control

Volumn 28, Issue 3, 2000, Pages 251-257

  Baltch, Aldona L ^a   Smith, Raymond P ^b   Franke, Mary A ^b   Ritz, William J ^b   Michelsen, Phyllis ^b   Bopp, Lawrence H ^b   Singh, Jaswant K ^b  

^a STRATTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISINFECTANT AGENT; MDI P; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; CANDIDA ALBICANS; COLONY FORMING UNIT; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISINFECTION; ELECTROLYSIS; LEGIONELLA PNEUMOPHILA; MORBIDITY; MORTALITY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TISSUE INJURY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0034131179     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2000.105287     Document Type: Conference Paper

References (15)

1. 1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999:12:147-79.
2. 2. Shimizu Y, Hurusawa T. Antiviral, antibacterial, and antifungal actions of electrolyzed oxidizing water through electrolysis. Dental J 1992;37:1055-62.
3. 3. Venkitanarayanan KS, Ezeike GOI, Hung Y-C, Doyle MP. Inactivation of Escherichia coil 0157:H7 and Listeria monocytogenes on plastic kitchen cutting boards by electrolyzed oxidizing water. J Food Protect 1999;62:857-60.
4. 4. Morrow RE, Welch WD. Inhibition of HIV activity in vitro and in vivo by MDI-P. Proceedings of the 10th International Congress on AIDS; 1994; Tokyo.
5. 5. Baltch AL, Smith RP, Franke M, Ritz W, Michelsen P, Singh JK. Antifungal activity of MDI-P against Candida albicans. Abstract A108. Proceedings of the 97th Annual Meeting of the American Society of Microbiology; 1997; Miami, Fla. p. 19.
6. 6. Baltch AL, Smith RP, Franke M, Ritz W, Michelsen P. Antibacterial activity of MDI-P against Legionella, pneumophila, Staphylococcus aureus, and Pseudomonas aeruginosa [abstract A24]. Proceedings of the 98th Annual Meeting of the American society of microbiology; 1998; Atlanta, Ga. p. 42.
7. 7. Hammer MC, Baltch AL, Sutphen NT, Smith RP, Bishop MB, Egy MA, et al. Pseudomonas aeruginosa: quantitation of maximum bactericidal capability and phagocytosis of normal human granulocytes. J Lab Clin Med 1981;98:938-48.
8. 8. Hammer MC, Baltch AL, Smith RP, Conroy JV, Bishop MB, Michelson P, et al. Human granulocyte activity against induced filimentous forms of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1988;32:1565-70.
9. 9. Louie A, Baltch AL, Smith RP, Franke MA, Ritz WJ, Singh JK, et al. Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal systemic candidiasis. J Infect Dis 1995;171:406-15.
10. 10. Baltch AL, Smith RP, Franke MA, Michelson PB. Antibacterial effect of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. Antimicrob Agents Chemother 1998;42:3153-6.
11. 11. Hayat MA. Basic techniques for transmission electron microscopy. New York: Academic Press; 1986. p. 92-5.
12. 12. Wilkes SS. Mathematical statistics. New York: John Wiley and Sons; 1962. p. 257.
13. 13. Stuart A, Ord JK. Kendall's advanced theory of statistics. Vol. 2. 5th ed. New York: Oxford University Press; 1991. p. 710, 1108-58.
14. 14. Trump BF, Jesudason ML, Jones RT. Ultrastructural features of diseased cells. In: Trump BF, Jones RT, editors. Diagnostic electron microscopy. New York: John Wiley and Sons; 1978. p. 1-88.
15. 15. Olmsted R, editor. APIC infection control and applied epidemiology-principles and practice. Philadelphia: Mosby; 1996.